152 results on '"Srirajaskanthan, Rajaventhan"'
Search Results
2. Sarcopenia and Neuroendocrine Neoplasms
3. Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
4. Outcomes and survival in patients with advanced intestinal neuroendocrine tumours on home parenteral nutrition, an international multicentre retrospective cohort study
5. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
6. Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
7. Increment in KI-67 proliferation indices over time is associated with worse survival outcomes in small-intestinal neuroendocrine tumours
8. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study
9. Overview and Pathophysiology of Neuroendocrine Neoplasms
10. The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.
11. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015
12. Tumour Staging: Ileum
13. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta‐analysis.
14. Feasibility of Home Parenteral Nutrition in Patients with Intestinal Failure Due to Neuroendocrine Tumours: A Systematic Review
15. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta‐analysis
16. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice
17. Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
18. Pivotal phase III COMPOSE trial to compare lutetium (177Lu) edotreotide with best standard of care in patients with well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors
19. The role of serotonin inhibition within the treatment of carcinoid syndrome
20. Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
21. COMPOSE: Pivotal Phase III Trial for Well-Differentiated Aggressive Grade 2/3 Gastroenteropancreatic Neuroendocrine Tumors Comparing 177Lu-edotreotide with Best Standard of Care
22. Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial.
23. Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours
24. Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England
25. Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012–2018
26. Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
27. Urine 5-HIAA levels and quality-of-life in neuroendocrine neoplasia. Is there an association?
28. Second primary malignancies in patients with a neuroendocrine neoplasm in England
29. Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment
30. Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry
31. Tumour Staging: Ileum
32. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
33. Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST
34. Nodal metastases in small rectal neuroendocrine tumours
35. Sex differences and survival of neuroendocrine neoplasia in England 2012-2018
36. Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995-2018
37. Mesenteric Variceal Haemorrhage and Ectopic Cushing’s Syndrome as Presenting Features of a Pancreatic Neuroendocrine Tumour Recurrence
38. Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.
39. Efficacy and safety of 177Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry.
40. Posterior reversible encephalopathy syndrome in a patient with a metastatic pancreatic neuroendocrine tumour and ectopic Cushing’s syndrome
41. Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis
42. O42 Incidence of neuroendocrine neoplasms in England 2015–2017
43. P253 First UK real-word data on patients with carcinoid syndrome on long-term telotristat therapy
44. P59 Artificial intelligence increases adenoma detection even in ‘high-detector’ colonoscopy: early evidence for human: machine interaction
45. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate : an analysis of the NETTER-1 study
46. Metachronous neuroendocrine neoplasms in England 2013-2015
47. Identification of soluble immune checkpoint receptor landscape in liver metastases of neuroendocrine neoplasms: A new perspective for immunotherapy
48. Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
49. The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN
50. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.